Drudge Retort: The Other Side of the News

Drudge Retort

User Info

LAMPLIGHTER

Subscribe to LAMPLIGHTER's blog Subscribe

Menu

Special Features

Sunday, September 20, 2026

The move came after the NIH director refused Trump's request to cut Harvard grants in an Oval Office meeting.


Vance's 'another chance' plea collides with a sharp attack on Democrats as the 2026 midterm battle intensifies read more


David Smith: Defiance from the supreme court and the Federal Reserve chair in one week ... how ever will the US president cope? read more


Anthropic has quietly set up a laboratory to do physical biology work as it pushes its artificial-intelligence ambitions into the world of drug science. read more


Saturday, September 19, 2026

OpenAI caught something unusual while training its latest model, GPT-5.6 Sol: It began leaving instructions for future versions of itself, telling them to conceal mistakes and misaligned behavior from the user.


Comments

Introduction to the Internet and World Wide Web (1997)
academic.oup.com

Yeah, all sunshine and roses back then.

Just like AI seems to be now.

OK, another prog rock tune ...

Triumvirat - Illusions On a Double Dimple (1973)
www.youtube.com

Warning, like most prog-rock tunes, it is not the usual three minute pop tune. This one runs over 20 minutes.


Enjoy!

@#7 ... He knows he is going to need to be protected from the People ...

Well, yeah.

I am sure he can see his approval ratings.

Trump says 'nobody will' build monuments for him after he's gone (September 4, 2026)
www.usatoday.com

... In a candid interview, President Donald Trump admitted that the various construction projects he has undertaken in Washington, DC, are an effort to build monuments to himself, saying, "Nobody will do it once I'm gone."

Trump's comments to New York Magazine came as the outlet asked the president about monuments such as the "triumphal arch" in the nation's capital.

"Nobody will do it once I'm gone. When I leave here, nobody will," Trump said. ...



Ukraine seems to be launching an attack on Russia that looks to be unprecedented.

For example ...

Ukrainian drones and missiles target Moscow, oil refinery in deadly attack: Officials
abcnews.com

... Plumes of smoke rose over Moscow on Sunday morning after a Ukrainian drone and missile attack on the city in which a major oil refinery was among the targets, according to the Russian capital's mayor.

Mayor Sergey Sobyanin said in posts to Telegram that 450 Ukrainian drones were shot down while heading toward the capital on Saturday night into Sunday morning, describing the latest attack as "unprecedented."

"Several drones did reach the territory of the Moscow Oil Refinery, and one hit a residential building. There were no fatalities," Sobyanin wrote, suggesting that the attack was "clearly planned to disrupt" the ongoing Russian parliamentary elections, voting in which is due to end on Sunday. ...



Moody Blues - Dream Sequence (1969)
www.youtube.com

"Live hand in hand, and together we will live on the threshold of a dream ..."

Yeah, they don't write lyrics like that anymore ...


Genesis - Firth Of Fifth (1973)
www.youtube.com

Genesis before Phil Collins took over the lead and diminished Genesis.

@#36

Excellent tune. Again, I first heard it on college radio.

Though, the CD I have credits the band as A3. Not Alabama 3.

Found this ...

Alabama 3
en.wikipedia.org

... Alabama 3 is a British musical group founded in Brixton, London, in 1995. Their track "Woke Up This Morning" was used for the opening credits of the TV series The Sopranos.[2][3] In the United States, the band is known as A3, to avoid legal conflict with the country music band Alabama.[4] ...

In any case, regardless of the band's name, an excellent tune.

Still more from the article ...

... When the boy was first diagnosed, he had a mass in the left lobe of his liver that measured 11.2 cm by 9.6 cm by 7.1 cm (4.4 3.8 2.8 inches).

The cancer had metastasized to his lungs, with indications that it had also spread to his bones.

The boy received three bouts of chemotherapy and had his primary liver tumor surgically removed, along with two operations to remove the cancer that had spread to his lungs.

Despite the interventions, the cancer rapidly returned, with a new tumor appearing in his lungs.

After the rapid recurrence, the boy was enrolled in the CARE study, the first human trial of an experimental form of CAR T cell therapy.

The boy received two doses of the experimental GPC3-CAR treatment, made from his own T cells, but engineered to recognize glypican-3 (GPC3), a protein that is highly expressed in liver cancers.

The researchers also engineered the therapy to include genes that would express the immune proteins interleukin"15 and interleukin"21, to boost the CAR T cells' longevity and tumor-killing ability, based on previous evidence from preclinical models.

The boy received two infusions of the GPC3-CAR treatment. After the first infusion, the patient showed a partial response, indicated by CT scans and falling levels of a protein called alpha-fetoprotein in his blood, which is indicative of tumor activity.

Eight weeks later he received a second dose of the therapy, and follow-up scans showed no remaining signs of the disease, apart from some residual scarring.

After 12 months, the boy was still disease-free -- an incredible result and turnaround for the patient and his family, given the severity of his illness before his participation in the trial. ...

[emphasis mine]

Drudge Retort
 

Home | Breaking News | Comments | User Blogs | Stats | Back Page | RSS Feed | RSS Spec | DMCA Compliance | Privacy